667 related articles for article (PubMed ID: 15940673)
1. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.
Aksoy E; Vanden Berghe W; Detienne S; Amraoui Z; Fitzgerald KA; Haegeman G; Goldman M; Willems F
Eur J Immunol; 2005 Jul; 35(7):2200-9. PubMed ID: 15940673
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
4. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
[TBL] [Abstract][Full Text] [Related]
5. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
6. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.
Oshiumi H; Sasai M; Shida K; Fujita T; Matsumoto M; Seya T
J Biol Chem; 2003 Dec; 278(50):49751-62. PubMed ID: 14519765
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis.
Johnson J; Albarani V; Nguyen M; Goldman M; Willems F; Aksoy E
J Biol Chem; 2007 May; 282(20):15022-32. PubMed ID: 17296604
[TBL] [Abstract][Full Text] [Related]
8. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
[TBL] [Abstract][Full Text] [Related]
9. LY294002 inhibits TLR3/4-mediated IFN-β production via inhibition of IRF3 activation with a PI3K-independent mechanism.
Zhao W; Qi J; Wang L; Zhang M; Wang P; Gao C
FEBS Lett; 2012 Mar; 586(6):705-10. PubMed ID: 22285490
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
[TBL] [Abstract][Full Text] [Related]
11. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
[TBL] [Abstract][Full Text] [Related]
12. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter.
Wang YY; Li L; Han KJ; Zhai Z; Shu HB
FEBS Lett; 2004 Oct; 576(1-2):86-90. PubMed ID: 15474016
[TBL] [Abstract][Full Text] [Related]
13. TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.
Ahmed S; Maratha A; Butt AQ; Shevlin E; Miggin SM
J Immunol; 2013 Mar; 190(5):2217-28. PubMed ID: 23365087
[TBL] [Abstract][Full Text] [Related]
14. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of inhibition of lipopolysaccharide-induced interferon-β production by 2-aminopurine.
Sugiyama T; Gotou T; Moriyama K; Kajiura N; Hasegawa T; Tomida J; Takahashi K; Komatsu T; Ueda H; Sato K; Tokoro S; Neri P; Mori H
Mol Immunol; 2012 Oct; 52(3-4):299-304. PubMed ID: 22750230
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.
Hardy MP; McGGettrick AF; O'Neill LA
Biochem J; 2004 May; 380(Pt 1):83-93. PubMed ID: 14960149
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide enhances Wnt5a expression through toll-like receptor 4, myeloid differentiating factor 88, phosphatidylinositol 3-OH kinase/AKT and nuclear factor kappa B pathways in human dental pulp stem cells.
He W; Wang Z; Zhou Z; Zhang Y; Zhu Q; Wei K; Lin Y; Cooper PR; Smith AJ; Yu Q
J Endod; 2014 Jan; 40(1):69-75. PubMed ID: 24331994
[TBL] [Abstract][Full Text] [Related]
19. Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation.
Sasai M; Oshiumi H; Matsumoto M; Inoue N; Fujita F; Nakanishi M; Seya T
J Immunol; 2005 Jan; 174(1):27-30. PubMed ID: 15611223
[TBL] [Abstract][Full Text] [Related]
20. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.
Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F
Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
